10-53822440-A-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033056.4(PCDH15):​c.5286T>A​(p.Pro1762Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,592,162 control chromosomes in the GnomAD database, including 110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 90 hom. )

Consequence

PCDH15
NM_033056.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.344

Publications

5 publications found
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
PCDH15 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 23
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-53822440-A-T is Benign according to our data. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-53822440-A-T is described in CliVar as Benign. Clinvar id is 46492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.344 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0685 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH15NM_033056.4 linkc.5286T>A p.Pro1762Pro synonymous_variant Exon 33 of 33 ENST00000320301.11 NP_149045.3 Q96QU1-1
PCDH15NM_001384140.1 linkc.4368-2210T>A intron_variant Intron 32 of 37 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkc.5286T>A p.Pro1762Pro synonymous_variant Exon 33 of 33 1 NM_033056.4 ENSP00000322604.6 Q96QU1-1
PCDH15ENST00000644397.2 linkc.4368-2210T>A intron_variant Intron 32 of 37 NM_001384140.1 ENSP00000495195.1 A0A2R8Y6C0

Frequencies

GnomAD3 genomes
AF:
0.00298
AC:
450
AN:
150818
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000666
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00152
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0747
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00655
AC:
1400
AN:
213664
AF XY:
0.00602
show subpopulations
Gnomad AFR exome
AF:
0.000475
Gnomad AMR exome
AF:
0.000221
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0878
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000143
Gnomad OTH exome
AF:
0.00437
GnomAD4 exome
AF:
0.00199
AC:
2868
AN:
1441226
Hom.:
90
Cov.:
32
AF XY:
0.00187
AC XY:
1339
AN XY:
715488
show subpopulations
African (AFR)
AF:
0.000344
AC:
11
AN:
31986
American (AMR)
AF:
0.000213
AC:
9
AN:
42278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25894
East Asian (EAS)
AF:
0.0639
AC:
2419
AN:
37846
South Asian (SAS)
AF:
0.000499
AC:
42
AN:
84122
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51850
Middle Eastern (MID)
AF:
0.000353
AC:
2
AN:
5668
European-Non Finnish (NFE)
AF:
0.0000690
AC:
76
AN:
1101972
Other (OTH)
AF:
0.00517
AC:
308
AN:
59610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
206
412
618
824
1030
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00298
AC:
450
AN:
150936
Hom.:
20
Cov.:
32
AF XY:
0.00320
AC XY:
236
AN XY:
73808
show subpopulations
African (AFR)
AF:
0.000664
AC:
27
AN:
40680
American (AMR)
AF:
0.00151
AC:
23
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.0747
AC:
378
AN:
5060
South Asian (SAS)
AF:
0.00146
AC:
7
AN:
4782
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000133
AC:
9
AN:
67844
Other (OTH)
AF:
0.00285
AC:
6
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000507
Hom.:
0
Bravo
AF:
0.00365

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 25, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 13, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 20, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Oct 28, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 28, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Usher syndrome type 1F Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Usher syndrome type 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
7.6
DANN
Benign
0.41
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58461416; hg19: chr10-55582200; COSMIC: COSV57405081; API